Dabomb Protein Biotech (ROCO:6578) Marketable Securities : NT$50.6 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Dabomb Protein Biotech's Marketable Securities for the quarter that ended in Mar. 2024 was NT$50.6 Mil.

Dabomb Protein Biotech's annual Marketable Securities declined from Dec. 2021 (NT$69.7 Mil) to Dec. 2022 (NT$36.8 Mil) but then increased from Dec. 2022 (NT$36.8 Mil) to Dec. 2023 (NT$49.5 Mil).

Dabomb Protein Biotech Marketable Securities Historical Data

The historical data trend for Dabomb Protein Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Marketable Securities Chart

Dabomb Protein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

2.42

47.91

69.73

36.84

49.47

Dabomb Protein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															50.16	49.17	50.68	49.47	50.56

Dabomb Protein Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Dabomb Protein Biotech (ROCO:6578) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Dabomb Protein Biotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dabomb Protein Biotech (ROCO:6578) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 52, Gongye 3rd Road, Annan District, Tainan, TWN, 709

Website

https://www.dabombprotein.com

Dabomb Protein Biotech Corp is a company specializing in antibiotic alternatives, and use postbiotics to boost immune strength and excel in innovative fermentation for improved plant protein utility. Their portfolio of products which include DBT-100 LS and DBT-100 HT , Liqui-TIDE bandage and LACTOTIDES HEALTH A+.

Dabomb Protein Biotech (ROCO:6578) Headlines

No Headlines